Skip To Main Content
{ "isEditMode": false, "isPublic": true, "context": "", "site": "campus-sanofi-cz", "currentLocale": "cs_CZ", "translationsPath": "", "cfViewerCountry": "US" }
[{ event: `metadata`,device: /(tablet|ipad|playbook|silk)|(android(?!.*mobi))/i.test(navigator.userAgent) ? 'tablet' : (/Mobile|iP(hone|od)|Android|BlackBerry|IEMobile|Kindle|Silk-Accelerated|(hpw|web)OS|Opera M(obi|ini)/.test(navigator.userAgent) ? 'mobile' : 'desktop'),platform: `magnolia`,language: `cs`,siteType: `advise`,brandWebsiteType: `multibrand`,region: `emea`,country: `czech republic`,target: `hcp`,brand: `Multi-Brand`,gbu: `GBU - Specialty care`,pageName: `Transplantační medicína` }, { event: `promomat_metadata` }]
Určeno pro odbornou veřejnost
Campus
Věda
Podpora Pacienta
Produkty
Farmakovigilance
Přihlásit se
Registrovat se
Campus
Věda
Podpora Pacienta
Produkty
Farmakovigilance
Přihlásit se
Registrovat se
Search Term
View Full Results
Transplantační medicína
Nejnovější trendy
Prozkoumejte nejčtenější články a videa na Campus Sanofi
Seřadit
Nejnovější
Nejstarší
Abecedně
Act Now for Your ACS Patients: Treat Aggressively, Combine and Start Early
Číst více
Act Now for Your ACS Patients: Treat Aggressively, Combine and Start Early
Číst více
Act Now for Your ACS Patients: Treat Aggressively, Combine and Start Early
Číst více
Caprini Score Responses to Prevent VTE in Patients Undergoing Varicose Vein Surgery
Číst více
Caprini Score Responses to Prevent VTE in Patients Undergoing Varicose Vein Surgery
Číst více
Caprini Score Responses to Prevent VTE in Patients Undergoing Varicose Vein Surgery
Číst více
Caprini Score Responses to Prevent VTE in Patients Undergoing Varicose Vein Surgery
Číst více
Caprini Score Responses to Prevent VTE in Patients Undergoing Varicose Vein Surgery
Číst více
Caprini Score Responses to Prevent VTE in Patients Undergoing Varicose Vein Surgery
Číst více
Advancing therapy in suboptimally controlled basal insulin-treated type 2 diabetes: Clinical outcomes with iGlarLixi versus premix BIAsp 30 in the SoliMix randomized controlled trial.
Číst více
Advancing therapy in suboptimally controlled basal insulin-treated type 2 diabetes: Clinical outcomes with iGlarLixi versus premix BIAsp 30 in the SoliMix randomized controlled trial.
Číst více
Advancing therapy in suboptimally controlled basal insulin-treated type 2 diabetes: Clinical outcomes with iGlarLixi versus premix BIAsp 30 in the SoliMix randomized controlled trial.
Číst více
«
‹
677
678
679
680
681
682
683
684
685
686
›
»